Ignite Creation Date:
2025-12-24 @ 9:27 PM
Ignite Modification Date:
2026-01-18 @ 5:20 PM
Study NCT ID:
NCT02102932
Status:
COMPLETED
Last Update Posted:
2015-09-24
First Post:
2014-03-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-05
Start Date Type:
None
Primary Completion Date:
2014-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-31
First Submit QC Date:
None
Study First Post Date:
2014-04-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-08-21
Results First Submit QC Date:
None
Results First Post Date:
2015-09-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-08-21
Last Update Post Date:
2015-09-24
Last Update Post Date Type:
ESTIMATED